Absolute and relative figures;Sex;Size of municipality of residence;Number of symptoms;Total
ABSOLUTE FIGURES;Both genders;Total;Total;5,884.8
ABSOLUTE FIGURES;Both genders;Total;One symptom;4,035.8
ABSOLUTE FIGURES;Both genders;Total;Two or more symptoms;1,849.0
ABSOLUTE FIGURES;Both genders;Less than or equal to 2,000 inhabitants;Total;344.6
ABSOLUTE FIGURES;Both genders;Less than or equal to 2,000 inhabitants;One symptom;227.5
ABSOLUTE FIGURES;Both genders;Less than or equal to 2,000 inhabitants;Two or more symptoms;117.1
ABSOLUTE FIGURES;Both genders;2,001 to 10,000 inhabitants;Total;898.2
ABSOLUTE FIGURES;Both genders;2,001 to 10,000 inhabitants;One symptom;585.0
ABSOLUTE FIGURES;Both genders;2,001 to 10,000 inhabitants;Two or more symptoms;313.2
ABSOLUTE FIGURES;Both genders;10,001 to 50,000 inhabitants;Total;1,488.2
ABSOLUTE FIGURES;Both genders;10,001 to 50,000 inhabitants;One symptom;993.4
ABSOLUTE FIGURES;Both genders;10,001 to 50,000 inhabitants;Two or more symptoms;494.7
ABSOLUTE FIGURES;Both genders;50,001 to 100,000 inhabitants;Total;638.4
ABSOLUTE FIGURES;Both genders;50,001 to 100,000 inhabitants;One symptom;473.8
ABSOLUTE FIGURES;Both genders;50,001 to 100,000 inhabitants;Two or more symptoms;164.6
ABSOLUTE FIGURES;Both genders;100,001 to 400,000 inhabitants;Total;1,458.9
ABSOLUTE FIGURES;Both genders;100,001 to 400,000 inhabitants;One symptom;958.3
ABSOLUTE FIGURES;Both genders;100,001 to 400,000 inhabitants;Two or more symptoms;500.6
ABSOLUTE FIGURES;Both genders;400,001 to 1,000,000 inhabitants;Total;414.3
ABSOLUTE FIGURES;Both genders;400,001 to 1,000,000 inhabitants;One symptom;258.7
ABSOLUTE FIGURES;Both genders;400,001 to 1,000,000 inhabitants;Two or more symptoms;155.6
ABSOLUTE FIGURES;Both genders;More than 1,000,000 inhabitants;Total;642.3
ABSOLUTE FIGURES;Both genders;More than 1,000,000 inhabitants;One symptom;539.1
ABSOLUTE FIGURES;Both genders;More than 1,000,000 inhabitants;Two or more symptoms;103.2
ABSOLUTE FIGURES;Males;Total;Total;2,513.3
ABSOLUTE FIGURES;Males;Total;One symptom;1,808.8
ABSOLUTE FIGURES;Males;Total;Two or more symptoms;704.6
ABSOLUTE FIGURES;Males;Less than or equal to 2,000 inhabitants;Total;126.7
ABSOLUTE FIGURES;Males;Less than or equal to 2,000 inhabitants;One symptom;70.4
ABSOLUTE FIGURES;Males;Less than or equal to 2,000 inhabitants;Two or more symptoms;56.3
ABSOLUTE FIGURES;Males;2,001 to 10,000 inhabitants;Total;375.9
ABSOLUTE FIGURES;Males;2,001 to 10,000 inhabitants;One symptom;254.0
ABSOLUTE FIGURES;Males;2,001 to 10,000 inhabitants;Two or more symptoms;121.9
ABSOLUTE FIGURES;Males;10,001 to 50,000 inhabitants;Total;634.4
ABSOLUTE FIGURES;Males;10,001 to 50,000 inhabitants;One symptom;445.0
ABSOLUTE FIGURES;Males;10,001 to 50,000 inhabitants;Two or more symptoms;189.4
ABSOLUTE FIGURES;Males;50,001 to 100,000 inhabitants;Total;282.1
ABSOLUTE FIGURES;Males;50,001 to 100,000 inhabitants;One symptom;222.6
ABSOLUTE FIGURES;Males;50,001 to 100,000 inhabitants;Two or more symptoms;59.6
ABSOLUTE FIGURES;Males;100,001 to 400,000 inhabitants;Total;642.7
ABSOLUTE FIGURES;Males;100,001 to 400,000 inhabitants;One symptom;434.1
ABSOLUTE FIGURES;Males;100,001 to 400,000 inhabitants;Two or more symptoms;208.6
ABSOLUTE FIGURES;Males;400,001 to 1,000,000 inhabitants;Total;133.7
ABSOLUTE FIGURES;Males;400,001 to 1,000,000 inhabitants;One symptom;95.5
ABSOLUTE FIGURES;Males;400,001 to 1,000,000 inhabitants;Two or more symptoms;38.2
ABSOLUTE FIGURES;Males;More than 1,000,000 inhabitants;Total;317.9
ABSOLUTE FIGURES;Males;More than 1,000,000 inhabitants;One symptom;287.3
ABSOLUTE FIGURES;Males;More than 1,000,000 inhabitants;Two or more symptoms;30.6
ABSOLUTE FIGURES;Females;Total;Total;3,371.4
ABSOLUTE FIGURES;Females;Total;One symptom;2,227.0
ABSOLUTE FIGURES;Females;Total;Two or more symptoms;1,144.4
ABSOLUTE FIGURES;Females;Less than or equal to 2,000 inhabitants;Total;217.9
ABSOLUTE FIGURES;Females;Less than or equal to 2,000 inhabitants;One symptom;157.1
ABSOLUTE FIGURES;Females;Less than or equal to 2,000 inhabitants;Two or more symptoms;60.8
ABSOLUTE FIGURES;Females;2,001 to 10,000 inhabitants;Total;522.3
ABSOLUTE FIGURES;Females;2,001 to 10,000 inhabitants;One symptom;331.0
ABSOLUTE FIGURES;Females;2,001 to 10,000 inhabitants;Two or more symptoms;191.3
ABSOLUTE FIGURES;Females;10,001 to 50,000 inhabitants;Total;853.8
ABSOLUTE FIGURES;Females;10,001 to 50,000 inhabitants;One symptom;548.5
ABSOLUTE FIGURES;Females;10,001 to 50,000 inhabitants;Two or more symptoms;305.3
ABSOLUTE FIGURES;Females;50,001 to 100,000 inhabitants;Total;356.2
ABSOLUTE FIGURES;Females;50,001 to 100,000 inhabitants;One symptom;251.2
ABSOLUTE FIGURES;Females;50,001 to 100,000 inhabitants;Two or more symptoms;105.0
ABSOLUTE FIGURES;Females;100,001 to 400,000 inhabitants;Total;816.2
ABSOLUTE FIGURES;Females;100,001 to 400,000 inhabitants;One symptom;524.1
ABSOLUTE FIGURES;Females;100,001 to 400,000 inhabitants;Two or more symptoms;292.0
ABSOLUTE FIGURES;Females;400,001 to 1,000,000 inhabitants;Total;280.6
ABSOLUTE FIGURES;Females;400,001 to 1,000,000 inhabitants;One symptom;163.2
ABSOLUTE FIGURES;Females;400,001 to 1,000,000 inhabitants;Two or more symptoms;117.4
ABSOLUTE FIGURES;Females;More than 1,000,000 inhabitants;Total;324.4
ABSOLUTE FIGURES;Females;More than 1,000,000 inhabitants;One symptom;251.8
ABSOLUTE FIGURES;Females;More than 1,000,000 inhabitants;Two or more symptoms;72.6
RELATIVE FIGURES;Both genders;Total;Total;100.00
RELATIVE FIGURES;Both genders;Total;One symptom;68.58
RELATIVE FIGURES;Both genders;Total;Two or more symptoms;31.42
RELATIVE FIGURES;Both genders;Less than or equal to 2,000 inhabitants;Total;100.00
RELATIVE FIGURES;Both genders;Less than or equal to 2,000 inhabitants;One symptom;66.02
RELATIVE FIGURES;Both genders;Less than or equal to 2,000 inhabitants;Two or more symptoms;33.98
RELATIVE FIGURES;Both genders;2,001 to 10,000 inhabitants;Total;100.00
RELATIVE FIGURES;Both genders;2,001 to 10,000 inhabitants;One symptom;65.13
RELATIVE FIGURES;Both genders;2,001 to 10,000 inhabitants;Two or more symptoms;34.87
RELATIVE FIGURES;Both genders;10,001 to 50,000 inhabitants;Total;100.00
RELATIVE FIGURES;Both genders;10,001 to 50,000 inhabitants;One symptom;66.76
RELATIVE FIGURES;Both genders;10,001 to 50,000 inhabitants;Two or more symptoms;33.24
RELATIVE FIGURES;Both genders;50,001 to 100,000 inhabitants;Total;100.00
RELATIVE FIGURES;Both genders;50,001 to 100,000 inhabitants;One symptom;74.21
RELATIVE FIGURES;Both genders;50,001 to 100,000 inhabitants;Two or more symptoms;25.79
RELATIVE FIGURES;Both genders;100,001 to 400,000 inhabitants;Total;100.00
RELATIVE FIGURES;Both genders;100,001 to 400,000 inhabitants;One symptom;65.69
RELATIVE FIGURES;Both genders;100,001 to 400,000 inhabitants;Two or more symptoms;34.31
RELATIVE FIGURES;Both genders;400,001 to 1,000,000 inhabitants;Total;100.00
RELATIVE FIGURES;Both genders;400,001 to 1,000,000 inhabitants;One symptom;62.44
RELATIVE FIGURES;Both genders;400,001 to 1,000,000 inhabitants;Two or more symptoms;37.56
RELATIVE FIGURES;Both genders;More than 1,000,000 inhabitants;Total;100.00
RELATIVE FIGURES;Both genders;More than 1,000,000 inhabitants;One symptom;83.94
RELATIVE FIGURES;Both genders;More than 1,000,000 inhabitants;Two or more symptoms;16.06
RELATIVE FIGURES;Males;Total;Total;100.00
RELATIVE FIGURES;Males;Total;One symptom;71.97
RELATIVE FIGURES;Males;Total;Two or more symptoms;28.03
RELATIVE FIGURES;Males;Less than or equal to 2,000 inhabitants;Total;100.00
RELATIVE FIGURES;Males;Less than or equal to 2,000 inhabitants;One symptom;55.57
RELATIVE FIGURES;Males;Less than or equal to 2,000 inhabitants;Two or more symptoms;44.43
RELATIVE FIGURES;Males;2,001 to 10,000 inhabitants;Total;100.00
RELATIVE FIGURES;Males;2,001 to 10,000 inhabitants;One symptom;67.57
RELATIVE FIGURES;Males;2,001 to 10,000 inhabitants;Two or more symptoms;32.43
RELATIVE FIGURES;Males;10,001 to 50,000 inhabitants;Total;100.00
RELATIVE FIGURES;Males;10,001 to 50,000 inhabitants;One symptom;70.14
RELATIVE FIGURES;Males;10,001 to 50,000 inhabitants;Two or more symptoms;29.86
RELATIVE FIGURES;Males;50,001 to 100,000 inhabitants;Total;100.00
RELATIVE FIGURES;Males;50,001 to 100,000 inhabitants;One symptom;78.88
RELATIVE FIGURES;Males;50,001 to 100,000 inhabitants;Two or more symptoms;21.12
RELATIVE FIGURES;Males;100,001 to 400,000 inhabitants;Total;100.00
RELATIVE FIGURES;Males;100,001 to 400,000 inhabitants;One symptom;67.55
RELATIVE FIGURES;Males;100,001 to 400,000 inhabitants;Two or more symptoms;32.45
RELATIVE FIGURES;Males;400,001 to 1,000,000 inhabitants;Total;100.00
RELATIVE FIGURES;Males;400,001 to 1,000,000 inhabitants;One symptom;71.42
RELATIVE FIGURES;Males;400,001 to 1,000,000 inhabitants;Two or more symptoms;28.58
RELATIVE FIGURES;Males;More than 1,000,000 inhabitants;Total;100.00
RELATIVE FIGURES;Males;More than 1,000,000 inhabitants;One symptom;90.38
RELATIVE FIGURES;Males;More than 1,000,000 inhabitants;Two or more symptoms;9.62
RELATIVE FIGURES;Females;Total;Total;100.00
RELATIVE FIGURES;Females;Total;One symptom;66.06
RELATIVE FIGURES;Females;Total;Two or more symptoms;33.94
RELATIVE FIGURES;Females;Less than or equal to 2,000 inhabitants;Total;100.00
RELATIVE FIGURES;Females;Less than or equal to 2,000 inhabitants;One symptom;72.09
RELATIVE FIGURES;Females;Less than or equal to 2,000 inhabitants;Two or more symptoms;27.91
RELATIVE FIGURES;Females;2,001 to 10,000 inhabitants;Total;100.00
RELATIVE FIGURES;Females;2,001 to 10,000 inhabitants;One symptom;63.38
RELATIVE FIGURES;Females;2,001 to 10,000 inhabitants;Two or more symptoms;36.62
RELATIVE FIGURES;Females;10,001 to 50,000 inhabitants;Total;100.00
RELATIVE FIGURES;Females;10,001 to 50,000 inhabitants;One symptom;64.24
RELATIVE FIGURES;Females;10,001 to 50,000 inhabitants;Two or more symptoms;35.76
RELATIVE FIGURES;Females;50,001 to 100,000 inhabitants;Total;100.00
RELATIVE FIGURES;Females;50,001 to 100,000 inhabitants;One symptom;70.51
RELATIVE FIGURES;Females;50,001 to 100,000 inhabitants;Two or more symptoms;29.49
RELATIVE FIGURES;Females;100,001 to 400,000 inhabitants;Total;100.00
RELATIVE FIGURES;Females;100,001 to 400,000 inhabitants;One symptom;64.22
RELATIVE FIGURES;Females;100,001 to 400,000 inhabitants;Two or more symptoms;35.78
RELATIVE FIGURES;Females;400,001 to 1,000,000 inhabitants;Total;100.00
RELATIVE FIGURES;Females;400,001 to 1,000,000 inhabitants;One symptom;58.17
RELATIVE FIGURES;Females;400,001 to 1,000,000 inhabitants;Two or more symptoms;41.83
RELATIVE FIGURES;Females;More than 1,000,000 inhabitants;Total;100.00
RELATIVE FIGURES;Females;More than 1,000,000 inhabitants;One symptom;77.63
RELATIVE FIGURES;Females;More than 1,000,000 inhabitants;Two or more symptoms;22.37